Le Lézard
Classified in: Covid-19 virus
Subjects: SVY, AVO

Making it Canada's Moment: a COVID economic recovery plan


SCARBOROUGH, ON, June 9, 2020 /CNW/ - Today the Coalition of Concerned Manufacturers and Businesses of Canada released a report - "Making it Canada's Moment" - aimed at reviving the economy and the manufacturing sector coast-to-coast. The report contains a series of recommendations to kick-start economic growth and create well-paying skilled jobs in the manufacturing and energy sectors. "This can be Canada's moment," said Coalition founder and President Jocelyn Bamford of the Scarborough, Ontario based organization. "Our manufacturing and energy sectors are the key to our country's economic recovery; when we support both, they will deliver!"

Key recommendations include:

Canada has vast reserves of oil and natural gas, two energy solutions that will continue to be in high demand in North America and on world markets.

CCMBC Board member Catherine Swift added "When considering how Canada can best recover from COVID-19, some groups have proposed a so called 'resilient recovery' with an exclusive focus on 'green' energy. Although this will be part of the solution, neglecting the oil and gas sectors and related manufacturing, which contributes so significantly to Canada's economy, will only ensure that our recovery is much weaker and prolonged than necessary."

The Coalition encourages all Canadians to join www.responsiblerecovery.ca to ensure we have a recovery that focuses on our 2nd and 3rd GDP contributors that are key to Canadian prosperity.

About CCMBC

The Coalition of Concerned Manufacturers and Businesses of Canada was formed in 2016 with a mandate to advocate for proactive and innovative policies that are conducive to manufacturing and business retention and growth in Canada. 

The full report can be accessed at www.ccmbc.ca

SOURCE Coalition of Concerned Manufacturers and Businesses of Canada


These press releases may also interest you

at 07:35
Arrowhead Pharmaceuticals, Inc. announced today that it has dosed the first subjects in a Phase 1/2a clinical trial (NCT06209177) of ARO-CFB, the company's investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and...

at 07:35
Fortive Corporation ("Fortive") today announced financial results for the first quarter of 2024. For the first quarter, net earnings were $207 million. For the same period, adjusted net earnings were $295 million, which excludes the $63 million...

at 07:30
Organizational redesign and rightsizing initiated across company to streamline structures, increase efficiency and reduce operating costsTogether with GSK, ended Pandemic Preparedness Agreement (PPA) with Federal Republic of Germany, after...

at 07:20
Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza (H5N1) virus, considered to be potential future pandemic threatStudy will assess monovalent vaccine candidate, encoding an...

at 07:20
CureVac N.V. ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger...

at 07:05
Healthcare Services Group, Inc. today reported results for the three months ended March 31, 2024. Ted Wahl, Chief Executive Officer, stated, "Our team delivered strong first quarter results, building on our positive momentum in 2023. During the...



News published on and distributed by: